Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, methyl ester
|
|
Sicherheit
Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, methyl ester Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
PF 1715 is a by-product from the R&D synthesis towards Bumetanide Lactose Adduct Impurity (B810335), the lactose adduct impurity of Bumetanide (B689550), a diuretic.Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, methyl ester Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, methyl ester Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 3)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd | 020-18102736 18102736234 |
LK@zlstandards.com | China | 8211 | 58 |
Jiangxi Yehong Hospital Technology Co., Ltd | 0793-15967982-804 13970348580 |
yehong_pt@yeah.net | China | 703 | 58 |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 |
3008058303@qq.com | China | 3001 | 58 |
- Benzoic acid, 3-(aminosulfonyl)-5-(butylamino)-4-phenoxy-, methyl ester
- methyl 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoate
- 28510-66-9